Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plaque-type Psoriasis”

171 trials

Showing 20 of 171 results

Large-scale testing (Phase 3)Study completedNCT02905331
What this trial is testing

Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 78
Testing effectiveness (Phase 2)Study completedNCT00770965
What this trial is testing

Phase II Efficacy Study Looking at a Single-dose of One of Three Dose Levels of AIN457 in Patients With Chronic Plaque-type Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Novartis Pharmaceuticals 80
Testing effectiveness (Phase 2)Study completedNCT00755196
What this trial is testing

Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type Psoriasis

Who this might be right for
Psoriasis
Pfizer 30
Testing effectiveness (Phase 2)Study completedNCT04629950
What this trial is testing

Rimegepant in Moderate Plaque-type Psoriasis

Who this might be right for
Psoriasis
Weill Medical College of Cornell University 41
Large-scale testing (Phase 3)Study completedNCT02471144
What this trial is testing

Pediatric Study in Children and Adolescents With Severe Plaque Psoriasis

Who this might be right for
Chronic Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 162
Testing effectiveness (Phase 2)Study completedNCT03000075
What this trial is testing

BI 655066 (Risankizumab) Compared to Placebo in Japanese Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie 182
Not applicableUnknownNCT01339741
What this trial is testing

Efficacy of Vitamin D3 for the Treatment of Psoriatic Patients With Vitamin D Deficiency and Insufficiency

Who this might be right for
Psoriasis VulgarisVitamin D Deficiency
Chulalongkorn University 30
Large-scale testing (Phase 3)Ended earlyNCT00358670
What this trial is testing

Long-Term Effects of Infliximab in the Treatment of Moderate to Severe Psoriasis [Extension of Study P04271, NCT00251641] (P04563)

Who this might be right for
Psoriasis
Merck Sharp & Dohme LLC 441
Large-scale testing (Phase 3)Study completedNCT01555125
What this trial is testing

First Study of Secukinumab in Pre-filled Syringes in Subjects With Chronic Plaque-type Psoriasis: Response at 12 Weeks

Who this might be right for
Moderate to Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 177
Large-scale testing (Phase 3)Study completedNCT01519089
What this trial is testing

A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis

Who this might be right for
Psoriasis
Pfizer 95
Large-scale testing (Phase 3)Study completedNCT03668613
What this trial is testing

Study to Assess the Long-term Safety, Tolerability, Efficacy of Secukinumab in Pediatric Patients of Age 6 to <18 Years, With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque-type Psoriasis
Novartis Pharmaceuticals 84
Testing effectiveness (Phase 2)Study completedNCT01071252
What this trial is testing

A Dose Ranging Study of AIN457 in Patients With Moderate to Severe Chronic Plaque-type Psoriasis

Who this might be right for
Chronic Plaque-type Psoriasis
Novartis Pharmaceuticals 125
Large-scale testing (Phase 3)Study completedNCT02394561
What this trial is testing

A 24-week, Multicenter, proSpective stUdy to Evaluate the PASI 90 Clinical Response Rate and the Safety PRofile of sEcukinuMab 300 mg in Cw6-negativE and Cw6-positive Patients With Moderate to Severe Chronic Plaque-type Psoriasis (SUPREME)

Who this might be right for
Plaque Type Psorisis
Novartis Pharmaceuticals 434
Testing effectiveness (Phase 2)Study completedNCT00230529
What this trial is testing

A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Plaque Type Psoriasis

Who this might be right for
Psoriasis
Centocor, Inc. 249
Testing effectiveness (Phase 2)Study completedNCT00604682
What this trial is testing

Open-Label,Single-Arm Pilot Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Preliminary Efficacy of CC1004 in Subjects With Severe Plaque Type Psoriasis

Who this might be right for
Psoriasis
Amgen 19
Testing effectiveness (Phase 2)Study completedNCT00669916
What this trial is testing

A Study Comparing AIN457 to Placebo in Subjects With a Diagnosis of Moderate to Severe Stable Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 36
Testing effectiveness (Phase 2)Study completedNCT02295865
What this trial is testing

Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 62
Early research (Phase 1)Study completedNCT01646567
What this trial is testing

SHP-141C in Plaque Type Psoriasis

Who this might be right for
Plaque Type Psoriasis
TetraLogic Pharmaceuticals 14
Testing effectiveness (Phase 2)Study completedNCT01537432
What this trial is testing

Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients

Who this might be right for
Psoriasis, Plaque-type Psoriasis
Novartis Pharmaceuticals 36
Large-scale testing (Phase 3)Study completedNCT01636687
What this trial is testing

Judging the Efficacy of Secukinumab in Patients With Psoriasis Using AutoiNjector: a Clinical Trial Evaluating Treatment Results (JUNCTURE)

Who this might be right for
Plaque-type Psoriasis
Novartis Pharmaceuticals 182
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation